We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
+33.13%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$1.84B
AUM Growth
+$507M
Cap. Flow
+$155M
Cap. Flow %
8.45%
Top 10 Hldgs %
76.86%
Holding
43
New
2
Increased
2
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
MBX
MBX Biosciences
MBX
+$82.7M
2
ZBIO
Zenas BioPharma
ZBIO
+$47M
3
TEM
Tempus AI
TEM
+$38M
4
IMA
ImageneBio Inc
IMA
+$50.6K

Top Sells

Rank Stock Value
1
MYND
Mynd.ai
MYND
+$7M
2
TUYA
Tuya Inc
TUYA
+$5.58M
3
AFMD
Affimed
AFMD
+$4

Sector Composition

Rank Sector Weight
1 Healthcare 90.15%
2 Consumer Staples 5.57%
3 Technology 3.35%
4 Communication Services 0.56%
5 Industrials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$313M 17.04%
3,745,262
– –
TEM
2
Tempus AI
TEM
$12.5B
$305M 16.61%
5,385,979
+813,169
+18% +$38M
VRNA
3
DELISTED
Verona Pharma
VRNA
$161M 8.75%
5,584,753
– –
RYTM icon
4
Rhythm Pharmaceuticals
RYTM
$6.66B
$152M 8.31%
2,909,956
– –
SVRA icon
5
Savara
SVRA
$1.08B
$104M 5.65%
24,471,264
– –
COUR icon
6
Coursera
COUR
$1.4B
$102M 5.57%
12,867,769
– –
MBX
7
MBX Biosciences
MBX
$2.94B
$93.9M 5.12%
+3,614,486
New +$82.7M
CRSP icon
8
CRISPR Therapeutics
CRSP
$5.01B
$74.6M 4.06%
1,587,854
– –
NN icon
9
NextNav
NN
$2.52B
$61.3M 3.34%
8,189,156
– –
ZBIO
10
Zenas BioPharma
ZBIO
$2.08B
$44.2M 2.41%
+2,613,948
New +$47M
GLUE icon
11
Monte Rosa Therapeutics
GLUE
$1.11B
$40.8M 2.22%
7,692,298
– –
TRVI icon
12
Trevi Therapeutics
TRVI
$2.14B
$38M 2.07%
11,370,376
– –
KRRO icon
13
Korro Bio
KRRO
$207M
$36.5M 1.99%
1,090,793
– –
PHAT icon
14
Phathom Pharmaceuticals
PHAT
$660M
$35.4M 1.93%
1,960,169
– –
AUPH icon
15
Aurinia Pharmaceuticals
AUPH
$2.15B
$29.1M 1.59%
3,969,834
– –
CVRX icon
16
CVRx
CVRX
$79.9M
$20.9M 1.14%
2,370,542
– –
BDTX icon
17
Black Diamond Therapeutics
BDTX
$113M
$19.4M 1.05%
4,448,757
– –
CELC icon
18
Celcuity
CELC
$4.05B
$18.6M 1.02%
1,250,001
– –
GOSS icon
19
Gossamer Bio
GOSS
$63.4M
$17.9M 0.98%
226,163
– –
ADAP
20
DELISTED
Adaptimmune Therapeutics
ADAP
$16.2M 0.88%
17,079,778
– –
NKTX icon
21
Nkarta
NKTX
$206M
$16.1M 0.88%
3,568,781
– –
ORIC icon
22
Oric Pharmaceuticals
ORIC
$1.28B
$15.4M 0.84%
1,500,000
– –
NEUE
23
DELISTED
NeueHealth
NEUE
$14.2M 0.78%
2,726,917
– –
INZY
24
DELISTED
Inozyme Pharma
INZY
$12.7M 0.69%
2,437,689
– –
GERN icon
25
Geron
GERN
$842M
$12.6M 0.69%
2,776,409
– –
1
2

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q3 2024 Portfolio in Review

As of Q3 2024, NEA Management Company held 43 positions worth $1.84B, up 38% from $1.33B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

NEA Management Company deployed $155M of net new capital in Q3 2024, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was MBX Biosciences: 3,614,486 shares worth $93.9M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Mynd.ai, an estimated $7M trimmed.

  • NEA Management Company's largest Q3 2024 buy was MBX Biosciences: 3,614,486 shares worth $93.9M.
  • NEA Management Company added most to Tempus AI in Q3 2024, an estimated $38M increase.
  • NEA Management Company's biggest Q3 2024 reduction was Mynd.ai, cutting an estimated $7M.
  • NEA Management Company fully exited Tuya Inc in Q3 2024, selling an estimated $5.58M.
  • NEA Management Company's ten largest holdings make up 77% of its $1.84B portfolio in Q3 2024.
  • NEA Management Company opened 2 new positions and closed 1 in Q3 2024.
  • NEA Management Company's portfolio value rose 38% quarter-over-quarter to $1.84B.

Based on NEA Management Company's 13F filing for Q3 2024, filed 14 Nov 2024.